Codexis, Inc. (LON:0I0X)

Market Cap	171.88M
Revenue (ttm)	41.72M
Net Income (ttm)	-47.43M
Shares Out	n/a
EPS (ttm)	-0.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	956
Average Volume	5,877
Open	2.640
Previous Close	2.531
Day's Range	2.540 - 2.640
52-Week Range	1.920 - 6.051
Beta	2.50
RSI	50.28
Earnings Date	Oct 30, 2025

About Codexis

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorp...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 188
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I0X

Financial Performance

In 2024, Codexis's revenue was $59.35 million, a decrease of -15.39% compared to the previous year's $70.14 million. Losses were -$65.28 million, -14.38% less than in 2023.

Financial numbers in USD